申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US20030229090A1
公开(公告)日:2003-12-11
Disclosed are compounds of formula (I):
1
wherein R
3
, R
5
, R
7
and R
8
are defined herein, which are useful as inhibitors SYK kinase and are thus useful for treating diseases resulting from inappropriate mast cell activation, which include allergic and inflammatory diseases. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
公开了式(I)的化合物:其中R3、R5、R7和R8如此定义,它们有用作SYK激酶抑制剂,并因此有用于治疗由不适当的肥大细胞活化引起的疾病,包括过敏和炎症性疾病。还公开了包含这些化合物的制药组合物和制备这些化合物的方法。